Inhibikase Therapeutics, Inc. (IKT)
1.66
-0.01
(-0.60%)
USD |
NASDAQ |
Jan 20, 11:58
Inhibikase Therapeutics Price: 1.66 for Jan. 20, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| CEL-SCI Corp. | 5.73 |
| AIM ImmunoTech, Inc. | 1.155 |
| IGC Pharma, Inc. | 0.2861 |
| NovaBay Pharmaceuticals, Inc. | 6.89 |
| Protalix Biotherapeutics, Inc. | 2.05 |
Price Related Metrics
| Price to Book Value | 2.761 |
| Earnings Yield | -34.36% |
| Market Cap | 201.30M |